한빛사논문 | BRIC

이원화 님의 논문 목록

성균관대학교

CV File 241 kb

The TOX-RAGE axis mediates inflammatory activation and lung injury in severe pulmonary infectious diseases
- Proc. Natl. Acad. Sci. USA, Jun 25 2024, 121 (26) | https://doi.org/10.1073/pnas.2319322121
- 2024-06
- 생명과학
- 한빛사논문
Nitric oxide-assisted mucus-walking zwitterionic nanocomplexes for synergistic treatment of severe respiratory infectious disease
- Mater. Today, Available online 12 December 2023 | https://doi.org/10.1016/j.mattod.2023.11.011
- 2023-12
- 바이오·의료융합
- 한빛사논문
Uniform Gold Nanostructure Formation via Weakly Adsorbed Gold Films and Thermal Annealing for Reliable Localized Surface Plasmon Resonance-Based Detection of DNase-I
- Small, 2023 May 28;e2302023 | https://doi.org/10.1002/smll.202302023
- 2023-06
- 바이오·의료융합
- 한빛사논문
Double-Action Disinfection with Silk Fibroin Gauze: Reliable Therapeutics to Prevent Infectious Complications
- ACS Mater. Lett., Publication Date:October 17, 2022 | https://doi.org/10.1021/acsmaterialslett.2c00598
- 2022-10
- 바이오·의료융합
- 한빛사논문
Human activity-driven self-powered hair follicle stimulation system
- Nano Energy, Available online 6 September 2022 | https://doi.org/10.1016/j.nanoen.2022.107772
- 2022-09
- 바이오·의료융합
- 한빛사논문
Body-mediated energy loss conversion for personalized cell vitalization
- Nano Energy, Volume 87, September 2021, 106209 | https://doi.org/10.1016/j.nanoen.2021.106209
- 2021-09
- 바이오·의료융합
- 한빛사논문
Cleavage-Responsive Biofactory T Cells Suppress Infectious Diseases-Associated Hypercytokinemia
- Adv. Sci., First published: 25 June 2022 | https://doi.org/10.1002/advs.202201883
- 2022-06
- 바이오·의료융합
- 한빛사논문
Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of COVID-19-associated cytokine storm
- Nano Today, Available online 8 April 2021 | https://doi.org/10.1016/j.nantod.2021.101149
- 2021-04
- 바이오·의료융합
- 한빛사논문
PEGylated Nanoparticle Albumin-Bound Steroidal Ginsenoside Derivatives Ameliorate SARS-CoV-2-Mediated Hyper-Inflammatory Responses
- Biomaterials, Available online 14 April 2021, 120827 | https://doi.org/10.1016/j.biomaterials.2021.120827
- 2021-04
- 바이오·의료융합
- 한빛사논문
[Letter]GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro
- Signal Transduct. Target. Ther., Published: 17 November 2020, 5, 267, 2020 | https://doi.org/10.1038/s41392-020-00391-5
- 2020-11
- 바이오·의료융합
- 한빛사논문

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기